New products

A women-led medical device company has announced the launch of a crowdfunding campaign aimed at raising additional funds to develop its … continue reading “Uterine Fibroids: Crowdfunding Campaign to Complete Technology Development”

DePuy Synthes Spine has announced the launch of the Spotlight® PL Access System, the first access system designed specifically for minimally invasive posterior-lateral fusion.

One of a flurry of spinal press announcements in advance of the NASS meeting, sees Choice Spine trumpeting the launch of its new Hawkeye™ Vertebral Body Replacement system.

Voiding dysfunction device company Uroplasty Inc. tells us that positive results from a long-term clinical pilot study using an implantable tibial nerve stimulation device will be presented at the Annual Meeting of the International Continence Society.

Boston Scientific Corporation has announced the U.S. and European launch of its Victory™ guidewire, designed to facilitate crossing of resistant lesions and the placement and exchange of balloon catheters or other interventional devices within the peripheral vasculature.

Smith & Nephew has chosen to announce the launch of its Trigen™ Low-Profile Screw at this week’s Orthopaedic Trauma Association meeting in Minneapolis. In a press release it says Trigen is the only truly “captured” head, low-profile screw on the market.

Covidien is showcasing some of its most innovative surgical products at the American College of Surgeons (ACS) annual clinical congress being held at McCormick Place in Chicago this week. Key featured products include the new Sonicision™ ultrasonic incision and hemostasis device as well as the company’s iDrive™ Ultra powered stapling system.

Orthopaedic and Sports Med company DePuy Mitek, Inc., has announced the launch of the Healix Advance™ Family of Suture Anchors, a comprehensive new system of rotator cuff anchor and instrumentation solutions. The company says its new anchor design will enable faster insertion into hard bone and maximise fixation and pull-out strength.

Boston Scientific Corporation has received CE Mark approval for use of its Vercise™ Deep Brain Stimulation System for the treatment of Parkinson’s disease. The company says this is the first and only commercially available DBS system to incorporate multiple independent current control, which is designed to selectively stimulate targeted areas in the brain.

Stentys is a French-headquartered medical technology company commercialising the world’s first and only self-apposing stent to treat Acute Myocardial Infarction (AMI). The company has announced the European commercial release of an enhanced stent-delivery system for its Self-Apposing® stent. The change involves use of a new catheter to implant the stent, which has a hydrophilic coating and an ergonomic handle that considerably facilitates stent implantation in tortuous vessels.

Orthopaedic and Sport Med device company DePuy Mitek, Inc.has announced the launch of Endurance Hip Solutions, a new system of instruments and devices that marks the company’s entry into the rapidly growing field of hip arthroscopy.

NeuroSigma, Inc., a Los Angeles-based medical device company, announced today that its Monarch™ eTNS™ system for the adjunctive treatment of epilepsy and depression will make its debut at the 10th European Congress on Epileptology, which takes place in London, England from September 30 to October 4, 2012.

Reliance® 4-Front™ Lead is designed to streamline surgical procedure for implantation of ICDs by improving handling and simplifying implantation.

BD Ultra-Fine™ Nano 4mm Pen Needles with PentaPoint™ Comfort are first to feature patented 5-bevel needle tip able to penetrate skin more easily for patients who require insulin injection

The Olympus DTAD includes 3 industry firsts in one device combining monopolar energy, a battery-powered debrider, and a malleable shaver blade that can be set at 40 degrees for adenoids, 15 degrees for tonsils, or anywhere in between.

The first clinical use of Alphatec Spine’s NEXoss,™ synthetic bone graft has been announced. The material is indicated for use in posterolateral spine fusions in conjunction with bone marrow aspirate, autograft bone and appropriate hardware.